Table 4.

Multivariate logistic regression analysis of factors associated with lower delivery rate of TTMS by HCWs

Variable	Patients’ peer supervision establish (n=235)	Intensive phase DOT (n=236)	Continuation phase DOT (n=236)	Regular medicine delivery (n=234)	Sputum sample collection (n=236)	Injection treatment for MDR-TB patient (n=234)	Providing supervision for newly released prison patient (n=236)
	OR (95% CI)	OR (95% CI)	OR (95% CI)	OR (95% CI)	OR (95% CI)	OR (95% CI)	OR (95% CI)
Gender
Female	Reference			Reference
Male	0.577 (0.258 to 1.270）			0.605 (0.320 to 1.147)
Age
>50		Reference
40–50		2.053 (0.985 to 4.279)
30–39		2.230 (0.947 to 5.248)
<30		Default
Professional Title
Non		Reference	Reference		Reference	Reference	Reference
Junior		0.424 (0.215 to 0.835)*	0.419 (0.228 to 0.771)*		0.458 (0.242 to 0.865)*	0.307 (0.159 to 0.594)	0.681 (0.364 to 1.273)
Intermediate		0.625 (0.233 to 1.787)	0.860 (0.355 to 2.804)		1.137 (0.432 to 2.995)	0.686 (0.258 to 1.827)	2.107 (0.829 to 5.353)
Deputy senior		0.276 (0.021 to 3.605)	0.415 (0.024 to 5.020)		1.644 (0.131 to 20.581)	0.809 (0.054 to 12.031)	2.534 (0.179 to 35.887)
Training frequency
0/6 months					Reference	Reference	Reference
1/6 months					2.474 (0.566 to 10.822)	3.533 (0.767 to 16.277)	4.752 (0.858 to 26.335)
2/6 months					2.890 (0.729 to 11.465)	2.217 (0.534 to 9.199)	2.568 (0.500 to 13.182)
3/6 months					0.776 (0.165 to 3.660)	0.607 (0.126 to 2.923)	0.990 (0.162 to 6.048)
>3/6 months					2.307 (0.432 to 12.327)	2.841 (0.503 to 16.-54)	3.346 (0.508 to 22.044)
Work satisfaction
Low satisfaction	Reference	Reference	Reference	Reference	Reference
Middle satisfaction	0.354 (0.168 to 0.745)*	0.449 (0.219 to 0.903)*	0.584 (0.312 to 1.095)	0.582 (0.309 to 1.094)	0.661 (0.304 to 1.533)
High satisfaction	0.182 (0.059 to 0.562)*	0.326 (0.140 to 0.766)*	0.347 (0.163 to 0.741)*	0.375 (0.165 to 0.853)	0.395 (0.160 to 0.826)*

*P<0.05.

DOT, directly observed therapy; MDR-TB, multidrug-resistance tuberculosis; TTMS, tuberculosis treatment management service.